中华全科医师杂志
中華全科醫師雜誌
중화전과의사잡지
CHINESE JOURNAL OF GENERAL PRACTITIONERS
2011年
4期
264-265
,共2页
吕秀云%崔丽英%朱天吉%董京生%所鸿
呂秀雲%崔麗英%硃天吉%董京生%所鴻
려수운%최려영%주천길%동경생%소홍
睡眠呼吸暂停,阻塞性%血栓栓塞
睡眠呼吸暫停,阻塞性%血栓栓塞
수면호흡잠정,조새성%혈전전새
Sleep apnea,obstructive%Thromboembolism
依据配对研究原则,对确诊的25例阻塞性睡眠呼吸暂停综合征(OSAHS)患者,按呼吸紊乱指数及最低血氧饱和度分为轻、中、重度,对所有患者进行双下肢静脉超声检查、D-二聚体、血常规检查.随着患者睡眠呼吸暂停低通气病情的加重,发生下肢静脉血栓数比例增高,轻度组中无一例发生下肢静脉血栓,中度组发生2例(2/10),重度组发生3例(3/8);D-二聚体水平增高,分别为轻度组(498±22)μg/L,中度组(659±43)μg/L,重度组(1528±181)μg/L;血红蛋白轻度组(150±8)g/L,中度组(183±15)g/L,重度组为(261±26)g/L.说明阻塞性睡眠呼吸暂停低通气综合征与静脉血栓栓塞症有一定关系.
依據配對研究原則,對確診的25例阻塞性睡眠呼吸暫停綜閤徵(OSAHS)患者,按呼吸紊亂指數及最低血氧飽和度分為輕、中、重度,對所有患者進行雙下肢靜脈超聲檢查、D-二聚體、血常規檢查.隨著患者睡眠呼吸暫停低通氣病情的加重,髮生下肢靜脈血栓數比例增高,輕度組中無一例髮生下肢靜脈血栓,中度組髮生2例(2/10),重度組髮生3例(3/8);D-二聚體水平增高,分彆為輕度組(498±22)μg/L,中度組(659±43)μg/L,重度組(1528±181)μg/L;血紅蛋白輕度組(150±8)g/L,中度組(183±15)g/L,重度組為(261±26)g/L.說明阻塞性睡眠呼吸暫停低通氣綜閤徵與靜脈血栓栓塞癥有一定關繫.
의거배대연구원칙,대학진적25례조새성수면호흡잠정종합정(OSAHS)환자,안호흡문란지수급최저혈양포화도분위경、중、중도,대소유환자진행쌍하지정맥초성검사、D-이취체、혈상규검사.수착환자수면호흡잠정저통기병정적가중,발생하지정맥혈전수비례증고,경도조중무일례발생하지정맥혈전,중도조발생2례(2/10),중도조발생3례(3/8);D-이취체수평증고,분별위경도조(498±22)μg/L,중도조(659±43)μg/L,중도조(1528±181)μg/L;혈홍단백경도조(150±8)g/L,중도조(183±15)g/L,중도조위(261±26)g/L.설명조새성수면호흡잠정저통기종합정여정맥혈전전새증유일정관계.
Twenty five patients with obstructive sleep apnea hypopnea syndrome (OSAHS) were classified as mild, moderate and severe grade according to apnea hyponea index and lowest oxyhemoglobin saturation.Lower limbs were examined with ultrasonography, blood routine and D-dimer levels were measured in all patients.The results revealed an increased incidence of deep vein thrombosis with the extent of obstructive sleep apnea.There was no deep vein thrombosis in patients with mild-grade OSAHS, while there were 2 in moderate and 3 in severe patients.The blood D-dimer levels were (498 ± 22) pg/L, (659 ±43 ) μg/L, ( 1528 ± 181 ) μg/L in mild, moderate and severe patients, respectively.The hemoglobin levels were (150 ± 8) g/L, ( 183 ± 15) g/L and (261 ± 26) g/L in mild, moderate and severe patients,respectively.There may be some association of obstructive sleep apnea hypopnea syndrome with deep vein thrombosis.